Axonics Completes Enrollment of U.S. FDA Pivotal Study for its Sacral Neuromodulation System

June 27, 2018

#Axonics completes enrollment of FDA pivotal trial for sacral nerve neuromod for treatment of urinary and bowel dysfunction. #BioelectronicMedicine

Press Release